Physician

Alfred Chung

According to 2025 Medicare claims, Alfred Chung (NPI: 1417375627) practices hematology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is UCSF MEDICAL GROUP BUSINESS SERVICES (NPI: 1477624104; TIN: 943281660) and primary practice location at 94702-2498.

Chung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 240 traditional Medicare patients, billed 15,480 HCPCS/CPT codes, and received $577,575 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 553 prescription claims across 74 beneficiaries totaling $4,228,051 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 36 claims. Open Payments data shows 38 records totaling $835,246. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,082 to $577,575. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,493 to $4,228,051. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	22	39	$4,082
2021	112	307	$36,649
2022	191	2,817	$128,588
2023	219	9,659	$366,217
2024	240	15,480	$577,575

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	12	$2,493
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	25	$3,284
2020	N/R	29	$48,517
2021	34	198	$591,499
2022	80	587	$2,646,934
2023	98	511	$3,061,716
2024	74	553	$4,228,051

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$550
2022	N/R	36	$1,192
2023	N/R	N/R	N/R
2024	N/R	36	$961

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	33	33	$145
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	143	355	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	58	81	$77
38222	Biopsy and aspiration of bone marrow sample for diagnosis	50	56	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	157	270	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	105	2,940	$2,416,126
Revlimid	Lenalidomide	67	1,869	$1,326,094
Lenalidomide	Lenalidomide	11	308	$158,812
Xarelto	Rivaroxaban	15	1,230	$23,338
Acyclovir	Acyclovir	74	5,280	$1,720

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8530	Cyclophosphamide; oral, 25 mg	N	N/R	18	$622
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$339

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$773	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	36	$834,473	Langley Porter Psychiatric Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alfred Chung?

Tedicare shows public-source Medicare data for Alfred Chung (NPI 1417375627), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alfred Chung have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alfred Chung?

Alfred Chung is linked to UCSF MEDICAL GROUP BUSINESS SERVICES (billing NPI 1477624104) in the available physician profile data.

Does Alfred Chung have Open Payments data?

Alfred Chung has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.